Inactivation of TIF1gamma cooperates with Kras to induce cystic tumors of the pancreas.
Inactivation of the Transforming Growth Factor Beta (TGFbeta) tumor suppressor pathway contributes to the progression of Pancreatic Ductal AdenoCarcinoma (PDAC) since it is inactivated in virtually all cases of this malignancy. Genetic lesions inactivating this pathway contribute to pancreatic tumor...
Main Authors: | , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2009-07-01
|
Series: | PLoS Genetics |
Online Access: | http://europepmc.org/articles/PMC2706992?pdf=render |
id |
doaj-cb97967f8e1a48baaf2fe656fecc984f |
---|---|
record_format |
Article |
spelling |
doaj-cb97967f8e1a48baaf2fe656fecc984f2020-11-25T01:53:32ZengPublic Library of Science (PLoS)PLoS Genetics1553-73901553-74042009-07-0157e100057510.1371/journal.pgen.1000575Inactivation of TIF1gamma cooperates with Kras to induce cystic tumors of the pancreas.David F VincentKai-Ping YanIsabelle TreilleuxFabien GayVanessa ArfiBastien KaniewskiJulien C MarieFlorian LepinasseSylvie MartelSophie Goddard-LeonJuan L IovannaPierre DubusStéphane GarciaAlain PuisieuxRuth RimokhNabeel BardeesyJean-Yves ScoazecRégine LossonLaurent BartholinInactivation of the Transforming Growth Factor Beta (TGFbeta) tumor suppressor pathway contributes to the progression of Pancreatic Ductal AdenoCarcinoma (PDAC) since it is inactivated in virtually all cases of this malignancy. Genetic lesions inactivating this pathway contribute to pancreatic tumor progression in mouse models. Transcriptional Intermediary Factor 1 gamma (TIF1gamma) has recently been proposed to be involved in TGFbeta signaling, functioning as either a positive or negative regulator of the pathway. Here, we addressed the role of TIF1gamma in pancreatic carcinogenesis. Using conditional Tif1gamma knockout mice (Tif1gamma(lox/lox)), we selectively abrogated Tif1gamma expression in the pancreas of Pdx1-Cre;Tif1gamma(lox/lox) mice. We also generated Pdx1-Cre;LSL-Kras(G12D);Tif1gamma(lox/lox) mice to address the effect of Tif1gamma loss-of-function in precancerous lesions induced by oncogenic Kras(G12D). Finally, we analyzed TIF1gamma expression in human pancreatic tumors. In our mouse model, we showed that Tif1gamma was dispensable for normal pancreatic development but cooperated with Kras activation to induce pancreatic tumors reminiscent of human Intraductal Papillary Mucinous Neoplasms (IPMNs). Interestingly, these cystic lesions resemble those observed in Pdx1-Cre;LSL-Kras(G12D);Smad4(lox/lox) mice described by others. However, distinctive characteristics, such as the systematic presence of endocrine pseudo-islets within the papillary projections, suggest that SMAD4 and TIF1gamma don't have strictly redundant functions. Finally, we report that TIF1gamma expression is markedly down-regulated in human pancreatic tumors by quantitative RT-PCR and immunohistochemistry supporting the relevance of these findings to human malignancy. This study suggests that TIF1gamma is critical for tumor suppression in the pancreas, brings new insight into the genetics of pancreatic cancer, and constitutes a promising model to decipher the respective roles of SMAD4 and TIF1gamma in the multifaceted functions of TGFbeta in carcinogenesis and development.http://europepmc.org/articles/PMC2706992?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
David F Vincent Kai-Ping Yan Isabelle Treilleux Fabien Gay Vanessa Arfi Bastien Kaniewski Julien C Marie Florian Lepinasse Sylvie Martel Sophie Goddard-Leon Juan L Iovanna Pierre Dubus Stéphane Garcia Alain Puisieux Ruth Rimokh Nabeel Bardeesy Jean-Yves Scoazec Régine Losson Laurent Bartholin |
spellingShingle |
David F Vincent Kai-Ping Yan Isabelle Treilleux Fabien Gay Vanessa Arfi Bastien Kaniewski Julien C Marie Florian Lepinasse Sylvie Martel Sophie Goddard-Leon Juan L Iovanna Pierre Dubus Stéphane Garcia Alain Puisieux Ruth Rimokh Nabeel Bardeesy Jean-Yves Scoazec Régine Losson Laurent Bartholin Inactivation of TIF1gamma cooperates with Kras to induce cystic tumors of the pancreas. PLoS Genetics |
author_facet |
David F Vincent Kai-Ping Yan Isabelle Treilleux Fabien Gay Vanessa Arfi Bastien Kaniewski Julien C Marie Florian Lepinasse Sylvie Martel Sophie Goddard-Leon Juan L Iovanna Pierre Dubus Stéphane Garcia Alain Puisieux Ruth Rimokh Nabeel Bardeesy Jean-Yves Scoazec Régine Losson Laurent Bartholin |
author_sort |
David F Vincent |
title |
Inactivation of TIF1gamma cooperates with Kras to induce cystic tumors of the pancreas. |
title_short |
Inactivation of TIF1gamma cooperates with Kras to induce cystic tumors of the pancreas. |
title_full |
Inactivation of TIF1gamma cooperates with Kras to induce cystic tumors of the pancreas. |
title_fullStr |
Inactivation of TIF1gamma cooperates with Kras to induce cystic tumors of the pancreas. |
title_full_unstemmed |
Inactivation of TIF1gamma cooperates with Kras to induce cystic tumors of the pancreas. |
title_sort |
inactivation of tif1gamma cooperates with kras to induce cystic tumors of the pancreas. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS Genetics |
issn |
1553-7390 1553-7404 |
publishDate |
2009-07-01 |
description |
Inactivation of the Transforming Growth Factor Beta (TGFbeta) tumor suppressor pathway contributes to the progression of Pancreatic Ductal AdenoCarcinoma (PDAC) since it is inactivated in virtually all cases of this malignancy. Genetic lesions inactivating this pathway contribute to pancreatic tumor progression in mouse models. Transcriptional Intermediary Factor 1 gamma (TIF1gamma) has recently been proposed to be involved in TGFbeta signaling, functioning as either a positive or negative regulator of the pathway. Here, we addressed the role of TIF1gamma in pancreatic carcinogenesis. Using conditional Tif1gamma knockout mice (Tif1gamma(lox/lox)), we selectively abrogated Tif1gamma expression in the pancreas of Pdx1-Cre;Tif1gamma(lox/lox) mice. We also generated Pdx1-Cre;LSL-Kras(G12D);Tif1gamma(lox/lox) mice to address the effect of Tif1gamma loss-of-function in precancerous lesions induced by oncogenic Kras(G12D). Finally, we analyzed TIF1gamma expression in human pancreatic tumors. In our mouse model, we showed that Tif1gamma was dispensable for normal pancreatic development but cooperated with Kras activation to induce pancreatic tumors reminiscent of human Intraductal Papillary Mucinous Neoplasms (IPMNs). Interestingly, these cystic lesions resemble those observed in Pdx1-Cre;LSL-Kras(G12D);Smad4(lox/lox) mice described by others. However, distinctive characteristics, such as the systematic presence of endocrine pseudo-islets within the papillary projections, suggest that SMAD4 and TIF1gamma don't have strictly redundant functions. Finally, we report that TIF1gamma expression is markedly down-regulated in human pancreatic tumors by quantitative RT-PCR and immunohistochemistry supporting the relevance of these findings to human malignancy. This study suggests that TIF1gamma is critical for tumor suppression in the pancreas, brings new insight into the genetics of pancreatic cancer, and constitutes a promising model to decipher the respective roles of SMAD4 and TIF1gamma in the multifaceted functions of TGFbeta in carcinogenesis and development. |
url |
http://europepmc.org/articles/PMC2706992?pdf=render |
work_keys_str_mv |
AT davidfvincent inactivationoftif1gammacooperateswithkrastoinducecystictumorsofthepancreas AT kaipingyan inactivationoftif1gammacooperateswithkrastoinducecystictumorsofthepancreas AT isabelletreilleux inactivationoftif1gammacooperateswithkrastoinducecystictumorsofthepancreas AT fabiengay inactivationoftif1gammacooperateswithkrastoinducecystictumorsofthepancreas AT vanessaarfi inactivationoftif1gammacooperateswithkrastoinducecystictumorsofthepancreas AT bastienkaniewski inactivationoftif1gammacooperateswithkrastoinducecystictumorsofthepancreas AT juliencmarie inactivationoftif1gammacooperateswithkrastoinducecystictumorsofthepancreas AT florianlepinasse inactivationoftif1gammacooperateswithkrastoinducecystictumorsofthepancreas AT sylviemartel inactivationoftif1gammacooperateswithkrastoinducecystictumorsofthepancreas AT sophiegoddardleon inactivationoftif1gammacooperateswithkrastoinducecystictumorsofthepancreas AT juanliovanna inactivationoftif1gammacooperateswithkrastoinducecystictumorsofthepancreas AT pierredubus inactivationoftif1gammacooperateswithkrastoinducecystictumorsofthepancreas AT stephanegarcia inactivationoftif1gammacooperateswithkrastoinducecystictumorsofthepancreas AT alainpuisieux inactivationoftif1gammacooperateswithkrastoinducecystictumorsofthepancreas AT ruthrimokh inactivationoftif1gammacooperateswithkrastoinducecystictumorsofthepancreas AT nabeelbardeesy inactivationoftif1gammacooperateswithkrastoinducecystictumorsofthepancreas AT jeanyvesscoazec inactivationoftif1gammacooperateswithkrastoinducecystictumorsofthepancreas AT reginelosson inactivationoftif1gammacooperateswithkrastoinducecystictumorsofthepancreas AT laurentbartholin inactivationoftif1gammacooperateswithkrastoinducecystictumorsofthepancreas |
_version_ |
1724990418974670848 |